by Cancer Immunology Research
Researchers believe endoglin (ENG), with its capacity to deliver comprehensive tumor targeting, could advance the use of chimeric antigen receptor (CAR) T-cell therapy to treat advanced sarcomas....
by Blood Advances
Researchers hope their novel but simple approach to rapid expansion of homogenous human type II innate lymphoid cells (ILC2) provides another option for preventing or treating graft-versus-host...
by Blood Advances
Research shows that ixazomib prevents development of moderate/severe chronic graft-versus-host disease (cGVHD), a complication of allogeneic transplantation (allo-HSCT) that investigators say can...
by Transplantation and Cellular Therapy - The Official Journal of ASTCT
Among children with thalassemia major, researchers say treosulfan-based conditioning prepares them for hematopoietic stem cell transplantation (allo-HSCT) without harming their natural growth...
by Blood
Scientists say myeloid-derived suppressor cells (MDSCs) engineered with human induced pluripotent stem cells (iPSC) may hold the key to migrating off-the-shelf MDSCs to the clinical setting, where...
by Nature
Tumor-specific antigens remain elusive in T-cell lymphomas (TCL), effectively limiting the impact of chimeric antigen receptor (CAR) T-cell therapy in this setting, but scientists are encouraged...